Use of Antimicrobial Agents in Hospitalized Children for Noninfectious Indications-Reference-Cited by-同舟云学术

Use of Antimicrobial Agents in Hospitalized Children for Noninfectious Indications

Published:2019-07-31 Issue:4 Volume:9 Page:490-493
ISSN:2048-7207
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Jaggi Preeti¹,Hamdy Rana F²,Lee Brian³,Hersh Adam L⁴,Gerber Jeffrey S⁵,Sharland Mike⁶,Terrill Cindy⁷,Newland Jason G⁷

Affiliation:

1. Division of Infectious Diseases, Department of Pediatrics, Emory University, Atlanta, Georgia

2. Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Division of Infectious Diseases, Children’s National Medical Center, Washington, DC

3. Department of Pediatrics, School of Medicine, Children’s Mercy, Kansas City, Missouri

4. Division of Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City

5. Division of Infectious Diseases, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Children’s Hospital of Philadelphia, United Kingdom

6. Institute of Infection and Immunity, St George’s University of London, United Kingdom

7. Division of Infectious Diseases, Department of Pediatrics, Washington University St Louis, Missouri

Abstract

Abstract In this point-prevalence study of 32 US children’s hospitals, we determined that 1.7% of hospitalized children received at least 1 antimicrobial agent for a non–infection-related reason; macrolides were used most commonly. Antimicrobial stewardship efforts to understand and affect use for these reasons is an unmet need; additional research considering the individual and societal effects of these antimicrobial-prescribing practices should be undertaken.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology and Child Health

Link

http://academic.oup.com/jpids/article-pdf/9/4/490/33761847/piz053.pdf

Reference22 articles.

1. Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS): a quality improvement collaborative;Newland;J Pediatric Infect Dis Soc,2018

2. Erythromycin stearate as prokinetic agent in postvagotomy gastroparesis;Mozwecz;Dig Dis Sci,1990

3. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants;Mansi;Neonatology,2011

4. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants;Ng;Cochrane Database Syst Rev,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Erythromycin as a Prokinetic on the Gut Microbiome in Children with Feeding Intolerance—A Pilot Study;Antibiotics;2023-11-08

2. Antibiotic-Associated Adverse Events in Hospitalized Children;Journal of the Pediatric Infectious Diseases Society;2021-01-16